Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 19882171)

1.

Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma.

Yang ZX, Wang D, Wang G, Zhang QH, Liu JM, Peng P, Liu XH.

J Cancer Res Clin Oncol. 2010 Apr;136(4):625-30. doi: 10.1007/s00432-009-0701-6. Epub 2009 Oct 31.

PMID:
19882171
2.

Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.

Choi BO, Jang HS, Kang KM, Lee SW, Kang YN, Chai GY, Choi IB.

Jpn J Clin Oncol. 2006 Mar;36(3):154-8. Epub 2006 Mar 6.

3.

Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.

Pan JJ, Zhang SW, Chen CB, Xiao SW, Sun Y, Liu CQ, Su X, Li DM, Xu G, Xu B, Lu YY.

J Clin Oncol. 2009 Feb 10;27(5):799-804. doi: 10.1200/JCO.2008.18.9670. Epub 2008 Dec 22.

4.
5.

[Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].

Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Zhu GY, Xu B.

Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):426-8. Chinese.

PMID:
16188130
6.

Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.

Wu SX, Chua DT, Deng ML, Zhao C, Li FY, Sham JS, Wang HY, Bao Y, Gao YH, Zeng ZF.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):761-9. Epub 2007 Jul 2. Review.

PMID:
17601682
7.

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1133-41.

PMID:
10613305
8.
9.

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.

Habib N, Salama H, Abd El Latif Abu Median A, Isac Anis I, Abd Al Aziz RA, Sarraf C, Mitry R, Havlik R, Seth P, Hartwigsen J, Bhushan R, Nicholls J, Jensen S.

Cancer Gene Ther. 2002 Mar;9(3):254-9.

10.

[Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].

Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Cai Y, Zhu GY, Xu B, Lü YY.

Zhonghua Yi Xue Za Zhi. 2003 Dec 10;83(23):2023-8. Chinese.

PMID:
14703408
11.

Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.

Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):193-200. doi: 10.1016/j.ijrobp.2009.01.064. Epub .

PMID:
19604653
12.

p53 gene therapy for pulmonary metastasis tumor from hepatocellular carcinoma.

Yu M, Chen W, Zhang J.

Anticancer Drugs. 2010 Oct;21(9):882-4. doi: 10.1097/CAD.0b013e32833db1bb.

PMID:
20679889
13.

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.

Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, Sun HC, Wang BL, Zhang JY, Jiang GL, Wang YQ.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):432-43.

PMID:
15667964
14.

Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.

Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):809-16.

PMID:
15708260
15.

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Cheng JC, Chuang VP, Cheng SH, Huang AT, Lin YM, Cheng TI, Yang PS, You DL, Jian JJ, Tsai SY, Sung JL, Horng CF.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):435-42.

PMID:
10802371
16.

Single-dose versus fractionated stereotactic radiotherapy for brain metastases.

Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, Kim HJ, Gwak HS, Yoo H, Lee SH.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):483-9. doi: 10.1016/j.ijrobp.2010.05.033. Epub 2010 Aug 26.

PMID:
20800386
17.

Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up.

Guan YS, Liu Y, Zou Q, He Q, La Z, Yang L, Hu Y.

J Zhejiang Univ Sci B. 2009 May;10(5):331-40. doi: 10.1631/jzus.B0820248.

18.

[Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].

Zhou ZH, Liu LM, Cheng WW, Meng ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):222-6. Chinese.

PMID:
16875612
19.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
20.

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT).

Combs SE, Thilmann C, Debus J, Schulz-Ertner D.

BMC Cancer. 2006 Sep 7;6:222.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk